EMBO Reports· 2026Q1
Koenzim A, TLR4'ü Aktive Ederek Makrofajların IL-4'e Yanıtını Güçlendiriyor
Coenzyme A activates TLR4 and enhances alternative macrophage activation in line with MyD88 agonism
- 0atıf
- Q1SCImago
- 2026yıl
Kısa özet
Eksojen koenzim A (CoA), zayıf bir TLR4 agonisti olarak davranarak makrofajları IL-4 sinyallerine daha duyarlı hale getirir ve alternatif aktivasyonu artırarak inflamasyonun çözülmesini sağlar.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Abstract Metabolites and metabolic cofactors can shape the innate immune response, though the pathways by which these molecules adjust inflammation remain incompletely understood. Here we show that the metabolic cofactor coenzyme A (CoA) enhances IL-4 driven alternative macrophage activation [M(IL-4)] in vitro and in vivo. Unexpectedly, we find that perturbations in intracellular CoA metabolism do not influence M(IL-4) differentiation. Rather, we discover that exogenous CoA is a weak TLR4 agonist which primes macrophages for increased receptivity to IL-4 signals and resolution of inflammation via MyD88. Mechanistic studies reveal MyD88-linked signals enhance IL-4 responsiveness, in part, by reshaping chromatin accessibility to enhance transcription of IL-4-linked genes. The results identify CoA as a host metabolic co-factor that influences macrophage function through an extrinsic TLR4-dependent mechanism and suggest that damage-associated molecular patterns (DAMPs) can prime macrophages for alternative activation and resolution of inflammation.
Yazarların özeti; kaynağından alınmıştır. EMBO Reports, 2026 · DOI ↗
Devamı Pofolia uygulamasında
Çıkarımlar, ana noktalar ve makaleye soru sorma; ilgi alanına göre her gün yeni özetler. Ücretsiz.
Web'de giriş yaparak açAlan: Nöroloji (Sinirbilim)
NeurologyNeuroscience